You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《亞洲股市》日經及韓股升幅擴至1.1%至1.4% 港股高開0.6%
阿思達克 02-01 09:29
藥廠強生研發的新冠疫苗於全球試驗中有效率僅66%,加上對沖基金與散戶投資者之間對峙未有平息跡象,市場對高度投機交易將加劇大市波動憂慮升溫,美股三大指數繼上周五急吐約2%後,期貨全面續跌0.2%-0.5%。不過,亞太區股市今早個別發展,受惠圓匯轉弱日經及經濟數據理想韓股分別升1.1%及1.4%,報27,956及3,017。

本港去年第四季GDP初值按年萎縮續收窄至3%,遜於市場預期萎縮2.1%,且已連續六季萎縮;季調後按季僅續增0.2%,也遜於市場預期增長0.8%及前值恢復增長2.8%。累計2020年全年,本港GDP初值萎縮至6.1%略遜預期,且為1961年有紀錄以來最差。不過,港股繼上周累吐1,164點或近4%後,今早扭四連跌,在小米(01810.HK)、創科(00669.HK)、騰訊(00700.HK)、申洲(02313.HK)及美團(03690.HK)高開1.9%-3.7%支持,恆指高開174點或0.6%報28,457。

滬指及深成繼上周分別累吐3.4%及5.2%後,前值今早延續過去兩連跌勢,低開近0.2%報3,477,後者扭兩連跌,高開0.1%報14,841。

星股連跌第三天,報2877,跌0.9%。新西蘭股市回落0.6%報13,042。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account